Ovarian cancer is frequently diagnosed after the disease has already spread to other parts of the body, leaving patients with a five-year survival rate of under 30 percent, according to researchers at the University of Maryland, Baltimore County (UMBC). Standard therapies often inflict heavy damage on healthy cells alongside malignant cells. New research published September … Read more
Ashlea Blackborough, a 34-year-old mother residing in Adelaide, Australia, was diagnosed with a rare subtype of ovarian clear cell carcinoma after initially dismissing recurring postpartum symptoms as common changes related to childbirth and breastfeeding, according to personal accounts published across multiple outlets including Newsweek. Postpartum Symptoms and Dismissed Early Warning Signs Following the birth of … Read more
Certain suspected cancers, including testicular, ovarian, and pediatric Wilms tumors, may be inadvertently spread if diagnosed via biopsy, according to internal medicine specialist Dr. Priyam Bordoloi. While tissue biopsies are generally the gold standard for cancer diagnosis, Dr. Bordoloi warns that puncturing these specific tumors can rupture the malignancy and seed cancer cells into the … Read more
Removing fallopian tubes during other abdominal or pelvic surgeries reduces a patient’s risk of developing the most common type of ovarian cancer by 78%, according to research published earlier this year. While ovaries have historically been the primary focus of ovarian cancer concerns, scientists and medical professionals now understand that the vast majority of these … Read more
A new peer-reviewed study published in the journal Diagnostics validates a multi-omic approach to detecting ovarian cancer, demonstrating that integrating lipidomic, metabolomic, and protein profiles offers higher clinical accuracy than single-modality tests. By analyzing 503 participants, researchers identified that ovarian cancer rewires multiple biological pathways simultaneously, providing the foundation for AOA Dx’s AKRIVIS GD diagnostic … Read more
Tennis Hall of Famer Chris Evert has confirmed that her ovarian cancer has returned, necessitating further surgery and a course of chemotherapy. The 18-time Grand Slam champion announced on Thursday that she will step back from her professional broadcasting commitments, including her scheduled appearance at Wimbledon, to focus on her health and recovery. Why Is … Read more
Researchers at Michigan State University have identified a protein, TPPP3, that allows ovarian cancer cells to resist chemotherapy by stabilizing their internal structural scaffolding. Published in Cell Reports, the study reveals that blocking this protein restores the effectiveness of drugs like cisplatin. By targeting the “tubulin code” rather than just DNA, scientists aim to prevent … Read more
The Rising Tide of Early-Onset Cancer: What the Data Tells Us For decades, cancer was largely viewed as a disease of aging. However, recent data from England is challenging that narrative. Research published in BMJ Oncology reveals a concerning trend: the incidence of several types of cancer is rising among adults under the age of … Read more
Ovarian Cancer Treatment: A New Focus on Fat Cells and the Tumor Microenvironment Ovarian cancer remains a formidable challenge in women’s health, with a low 5-year survival rate for advanced-stage patients – below 30%. Traditional treatments like surgery, chemotherapy, and targeted therapies often fall short, prompting researchers to explore novel approaches. A recent study is … Read more
Fertility Treatments and Cancer Risk: What the Latest Research Reveals A recent study published in JAMA Network Open has shed light on the complex relationship between medically assisted reproduction (MAR) and cancer risk in women. While overall cancer incidence among those who undergo fertility treatments remains comparable to the general population, certain cancer types appear … Read more